187.34BMarket Cap
20.36P/E TTM
GILD Balance Sheet
You can check out the annual or quarterly balance sheets of Gilead Sciences Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing GILD stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Gilead Sciences Inc Have?
In its most recent quarterly, Gilead Sciences Inc had 3.18B in cash and cash equivalents.
How Much Are Gilead Sciences Inc's Total Liabilities?
Gilead Sciences Inc reported 36.41B in total liabilities as of the latest reported quarter, including 11.81B in current liabilities and 24.59B in non-current liabilities.
What Are Gilead Sciences Inc's Total Assets?
As of the latest reported quarter, Gilead Sciences Inc's total assets were 59.02B, consisting of 18.34B in current assets and 40.68B in non-current assets.
How Much Shareholders' Equity Does Gilead Sciences Inc Have?
Gilead Sciences Inc reported 22.62B in total shareholders' equity as of the latest reported quarter.